Baxter to Present at UBS Genomics 2.0 and MedTech Innovations Summit

DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a leading global medical products company, will present at the UBS Genomics 2.0 and MedTech Innovations Summit on Thursday, August 12, 2021 in Laguna Beach, Calif. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 10:00 a.m. Pacific Time.

The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through August 11, 2022.

About Baxter

Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on Twitter, LinkedIn and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210729005968/en/

Media Contact
Steve Brett, (224) 948-5353
[email protected]

Investor Contact
Clare Trachtman, (224) 948-3020

Source: Baxter International Inc.

You May Also Be Interested In

• AngioDynamics Reports Record Fiscal Year 2026 Fourth Quarter and Full Year Financial Results; Continued Execution Drives Med Tech Growth and Full-Year Profitability
• Office of Strategic Capital Founding Director Dr. Jason Rathje Joins Arkenstone Defense as Executive Chairman of the Board
• BioTalent Canada and Fairleigh Dickinson University Vancouver Partner to Strengthen Life Sciences Talent Development